Abstract
Radiolabelled peptides are of increasing interest in nuclear medicine. Radiolabelled peptides are an emerging class of radiopharmaceuticals that share chemical and biological properties. The field of radiopharmaceuticals has witnessed continuous evolution thanks to the immense contributions of scientists from diverse disciplines such as radiochemistry, inorganic chemistry, organic chemistry, biochemistry, physiology and pharmacology. One of the challenges in the coming years will be to take advantage of the potentials of radiolabelled peptides to formulate clinically useful radiopharmaceuticals. The major constituent of a radiopharmaceutical is the radionuclide and the search for new radionuclides to improve the availability of diagnostic and therapeutic radiopharmaceuticals is continuing. This paper reviews most of the radiolabelled peptides that have been tested in animals and humans.
Keywords: Nuclear medicine, radionuclide, radiolabelled peptide, diagnostic and therapeutic radiopharmaceutical, therapeutic targeting
Current Radiopharmaceuticals
Title: Radiolabelled Peptides: Eon in Radiopharmaceutical
Volume: 2 Issue: 3
Author(s): Vikash Kumar, Permender Rathee, Kanchan Kohli, Hema Chaudhary and Sushila Rathee
Affiliation:
Keywords: Nuclear medicine, radionuclide, radiolabelled peptide, diagnostic and therapeutic radiopharmaceutical, therapeutic targeting
Abstract: Radiolabelled peptides are of increasing interest in nuclear medicine. Radiolabelled peptides are an emerging class of radiopharmaceuticals that share chemical and biological properties. The field of radiopharmaceuticals has witnessed continuous evolution thanks to the immense contributions of scientists from diverse disciplines such as radiochemistry, inorganic chemistry, organic chemistry, biochemistry, physiology and pharmacology. One of the challenges in the coming years will be to take advantage of the potentials of radiolabelled peptides to formulate clinically useful radiopharmaceuticals. The major constituent of a radiopharmaceutical is the radionuclide and the search for new radionuclides to improve the availability of diagnostic and therapeutic radiopharmaceuticals is continuing. This paper reviews most of the radiolabelled peptides that have been tested in animals and humans.
Export Options
About this article
Cite this article as:
Kumar Vikash, Rathee Permender, Kohli Kanchan, Chaudhary Hema and Rathee Sushila, Radiolabelled Peptides: Eon in Radiopharmaceutical, Current Radiopharmaceuticals 2009; 2 (3) . https://dx.doi.org/10.2174/1874471010902030199
DOI https://dx.doi.org/10.2174/1874471010902030199 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamin D Receptor Agonists: Opportunities and Challenges in Drug Discovery
Current Topics in Medicinal Chemistry Multidrug Resistance: Retrospect and Prospects in Anti-Cancer Drug Treatment
Current Medicinal Chemistry Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis
Current Drug Targets - Inflammation & Allergy Targeting the Lung: Preclinical and Comparative Evaluation of Anticancer Aerosols in Dogs with Naturally Occurring Cancers
Current Cancer Drug Targets Down Regulation of Differentiated Embryo-Chondrocyte Expressed Gene 1 is Related to the Decrease of Osteogenic Capacity
Current Drug Targets Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer
Current Organic Chemistry Aloperine Induces Apoptosis by a Reactive Oxygen Species Activation Mechanism in Human Ovarian Cancer Cells
Protein & Peptide Letters Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults
Current Medicinal Chemistry Modulation of Cellular Response to Anticancer Treatment by Caffeine: Inhibition of Cell Cycle Checkpoints, DNA Repair and More
Current Pharmaceutical Biotechnology A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets Paclitaxel Efficacy is Increased by Parthenolide via Nuclear Factor- KappaB Pathways in In Vitro and In Vivo Human Non–Small Cell Lung Cancer Models
Current Cancer Drug Targets Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors
Recent Patents on Anti-Cancer Drug Discovery Double Point Modified Analogs of Vitamin D as Potent Activators of Vitamin D Receptor
Current Pharmaceutical Design NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target
Current Drug Targets Is Intake of Flavonoid-Based Food Supplements During Pregnancy Safe for the Developing Child? A Literature Review
Current Drug Targets Histotype in Non-Small Cell Lung Cancer Therapy and Staging: The Emerging Role of an Old and Underrated Factor
Current Respiratory Medicine Reviews Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision
Anti-Cancer Agents in Medicinal Chemistry Viral Vectors in Cancer Immunotherapy: Which Vector for Which Strategy?
Current Gene Therapy NF-κB Blockers Gifted by Mother Nature: Prospectives in Cancer Cell Chemosensitization
Current Pharmaceutical Design Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation
Current Pharmacogenomics and Personalized Medicine